|
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines.
The web pages are not kept up to date and are for demonstration purposes only.
For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
|
BACK TO LIST |
European Patient Summary
|
|
|
|||||||||||||||||||
Problem list
| Condition | Onset Date | Status |
|---|---|---|
| Chronic kidney disease stage 3 | 2024-07-27 | active |
| Proteinuria due to type 2 diabetes mellitus | 2024-07-27 | active |
| Disorder of kidney due to diabetes mellitus | 2019-03-09 | active |
| Chronic kidney disease stage 2 | 2019-03-09 | active |
| Microalbuminuria due to type 2 diabetes mellitus | 2019-03-09 | active |
| Transformed migraine | 2014-02-15 | active |
| Metabolic syndrome X | 2013-02-02 | active |
| Hypertriglyceridemia | 2010-01-16 | active |
| Type 2 diabetes mellitus | 2009-01-10 | active |
| Essential hypertension | 2009-01-10 | active |
| Emphysematous bronchitis | 2006-01-07 | active |
| Anemia | 2006-01-07 | active |
| Recurrent urinary tract infection | 2002-10-13 | active |
Medication list
| Medication | Since | Form | Dosage | Reason |
|---|---|---|---|---|
| insulin isophane human 70 UNT/ML / insulin regular human 30 UNT/ML Injectable Suspension [Humulin] | 2025-07-12 | 10 units subcutaneously before breakfast and 10 units subcutaneously before dinner | Diabetes mellitus type 2 (disorder) | |
| Albuterol (as albuterol sulfate) 5 mg/mL solution for inhalation | 2025-07-12 | Solution for inhalation | 2.5 mg (0.5 mL of 5 mg/mL solution) via nebulizer every 4 to 6 hours as needed | Chronic obstructive bronchitis (disorder) |
| Amlodipine (as amlodipine besylate) 2.5 mg oral tablet | 2025-07-12 | Oral tablet | 1 tablet (2.5 mg) by mouth once daily | Essential hypertension (disorder) |
| Hydrochlorothiazide 25 mg oral tablet | 2025-07-12 | Oral tablet | 1 tablet (25 mg) by mouth once daily | Essential hypertension (disorder) |
| Lisinopril 10 mg oral tablet | 2025-07-12 | Oral tablet | 1 tablet (10 mg) by mouth once daily | Essential hypertension (disorder) |
| 60 ACTUAT Fluticasone propionate 0.25 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler | 2025-07-12 | 1 inhalation (250 mcg/50 mcg) twice daily | Chronic obstructive bronchitis (disorder) | |
| Acetaminophen 300 mg and codeine phosphate 15 mg oral tablet | 2025-07-12 | Oral tablet | 1 tablet (300 mg/15 mg) by mouth every 4 to 6 hours as needed for pain. Maximum 6 tablets per day. | |
| Abuse-Deterrent 12 HR Oxycodone Hydrochloride 10 MG Extended Release Oral Tablet [Oxycontin] | 2025-07-12 | 1 tablet (10 mg) every 12 hours |
Allergies and Intolerances
| No known allergies or intolerances |
Procedure History list
| Procedure | Date | Reason |
|---|---|---|
| Postoperative care | 2025-05-04 | Chronic obstructive bronchitis (disorder) |
| Lung volume reduction surgery | 2025-05-03 | Chronic obstructive bronchitis (disorder) |
| Spirometry | 2024-12-28 | Chronic obstructive bronchitis (disorder) |
| Medication reconciliation | 2024-12-28 | - |
| Assessment of health and social care needs | 2024-12-28 | - |
| Screening for drug abuse | 2024-12-28 | - |
| Screening for domestic abuse | 2024-12-28 | - |
| Assessment of substance use | 2024-12-28 | - |
| Depression screening | 2021-04-17 | - |
| Depression screening using PHQ-9 (Patient Health Questionnaire 9) score | 2021-04-17 | - |
| 2021-04-17 | - |
Immunizations list
| Vaccine | Date |
|---|---|
| Influenza virus antigen only vaccine product | 2025-06-14 |
| Clostridium tetani toxoid antigen adsorbed only vaccine product | 2021-11-13 |
| Hepatitis A virus antigen only vaccine product | 2021-05-15 |
| SARS-CoV-2 mRNA vaccine | 2021-05-08 |
Care Plan
| Active Planned Care | Date | Reason |
|---|---|---|
| Therapy | 2014-03-28 | - |
| Lifestyle education regarding hypertension | 2009-01-10 | Essential hypertension (disorder) |
| Diabetes self management plan | 2009-01-10 | Diabetes mellitus type 2 (disorder) |
| Chronic obstructive pulmonary disease clinical management plan | 2006-01-07 | Chronic obstructive bronchitis (disorder) |
History of Past Illness
| Condition | Period | Status |
|---|---|---|
| Acute viral pharyngitis | 2021-05-01 – 2021-05-11 | inactive |
| Viral sinusitis | 2017-11-11 – 2017-12-01 | inactive |
Vital Signs
| Vital Signs | 2025-07-12 | 2025-06-14 |
|---|---|---|
| Body Height | 170 cm | 170 cm |
| Pain severity - 0-10 verbal numeric rating [Score] - Reported | 3 {score} | 4 {score} |
| Body Weight | 79.8 kg | 79.8 kg |
| Body mass index (BMI) [Ratio] | 27.6 kg/m2 | 27.6 kg/m2 |
| Diastolic Blood Pressure | 82 mm[Hg] | 78 mm[Hg] |
| Systolic Blood Pressure | 98 mm[Hg] | 100 mm[Hg] |
| Heart rate | 71 /min | 66 /min |
| Respiratory rate | 14 /min | 13 /min |